AstraZeneca's Baxdrostat achieves breakthrough blood pressure reductions in Phase III Bax24 trial
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
Relmada expects to initiate its Phase 3 program in the first half of 2026
Poviztra is a second brand of Wegovy
Comirnaty, Pfizer’s COVID-19 prevention vaccine, reported global sales of $1.15 billion
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
Cupid has been allocated approximately 23.4 million units of female condoms per year
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Subscribe To Our Newsletter & Stay Updated